GlassScriptPhysician profile
Ferdinand J Plavidal
NPI 1649244039
$1,994.32
in general payments reported to CMS, 2019-2025
22 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $207 · 2021: $306 · 2022: $276 · 2023: $426 · 2024: $179 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $358.04 | 2019-2023 | |
| Myovant Sciences INC. | $230.14 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $210.07 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $192.39 | 2023-2025 | |
| Therapeuticsmd, INC. | $162.98 | 2019-2020 | |
| Abbvie INC. | $151.78 | 2020-2023 | |
| Astellas Pharma US INC | $146.99 | 2019-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $126.59 | 2019-2024 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $75.00 | 2019-2025 | Slynd |
| Avion Pharmaceuticals | $55.43 | 2020-2022 | |
| Duchesnay USA Incorporated | $50.31 | 2019 | |
| Millicent US INC | $32.46 | 2019-2020 | |
| Allergan, INC. | $29.30 | 2019 | |
| Innovation Technologies INC | $28.81 | 2024 | Irrisept |
| Lupin INC. | $24.35 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.64 | 2023 | Oasis Micro |
| Evofem Biosciences, INC. | $20.21 | 2023 | Phexxi |
| Acessa Health INC. | $20.13 | 2019 | |
| Agile Therapeutics, INC. | $18.49 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.85 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.56 | 2019 | |
| Minerva Surgical, INC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferdinand Plavidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.